Clinical Trials List
2026-03-16 - 2029-01-31
Phase III
Not yet recruiting2
Recruiting10
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Kai-Ling Lee 無
- Shang-Fu Hsu 無
- Mei-Chuan Chen 無
- 高冠鈞 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 蕭慈慧 無
- Chi-Lu Chiang 無
- Hsu-ching Huang 無
- Chia-I Shen 無
- 趙恒勝 無
- 廖映庭 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- Seu-Chun Yang 無
- Po-Lan Su 無
- Chun-Hui Lee 無
- Chin-Wei Kuo 無
- 蔡政軒 無
- Chian-Wei Chen 無
- 林建佑 無
- 周昀澤 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Chi Lin 無
- Chong-Jen Yu 無
- James Chih-Hsin Yang 無
- 陳冠宇 無
- 廖唯昱 無
- CHAO-CHI HO CHAO-CHI HO 無
- 黃俊凱 無
- 吳尚俊 無
- 許嘉林 無
- Jih-Hsiang Lee 無
- 蔡子修 無
- 楊景堯 無
- 錢穎群 無
- 徐偉勛 無
- 廖斌志 無
- YEN-TING LIN 無
- 于鎧綸 無
- 黃得瑞 無
- 張立群 無
- 黃信端 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Ta Yang 無
- 柯皓文 無
- Chien-Ying Liu 無
- Chih-Liang Wang 無
- 林定佑 無
- Ping-Chih Hsu 無
- 邱立忠 無
- 枋岳甫 無
- Chih-Hung Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jen Yang 無
- Inn-Wen Chong 無
- 李玫萱 無
- Ying-Ming Tsai Tsai 無
- KUAN-LI WU 無
- 莊正皓 無
- 李岱晃 無
- 郭家祐 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
462 participants
